{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:10:51Z","timestamp":1791544251766,"version":"4.3.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-07429-0","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T22:18:37Z","timestamp":1751408317000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The impact of oxidative stress on symptoms associated with multiple sclerosis"],"prefix":"10.1038","volume":"15","author":[{"given":"Raquel","family":"Pi\u00f1ar-Morales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Bautista-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jose","family":"Garc\u00eda-Mansilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Aliaga-Gaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Vives-Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Barrero-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"7429_CR1","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston, A. & Coles, A. Multiple sclerosis. Lancet 372, 1502\u20131517. https:\/\/doi.org\/10.1016\/S0140-6736(08)61620-7 (2008).","journal-title":"Lancet"},{"key":"7429_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMra1401483","volume":"378","author":"DS Reich","year":"2018","unstructured":"Reich, D. S., Lucchinetti, C. F. & Calabresi, P. A. Multiple sclerosis. N Engl. J. Med. 378, 169\u2013180. https:\/\/doi.org\/10.1056\/NEJMra1401483 (2018).","journal-title":"N Engl. J. Med."},{"key":"7429_CR3","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.bbadis.2015.09.018","volume":"1862","author":"H Lassmann","year":"2016","unstructured":"Lassmann, H. & van Horssen, J. Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions. Biochim. Biophys. Acta. 1862, 506\u2013510. https:\/\/doi.org\/10.1016\/j.bbadis.2015.09.018 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"7429_CR4","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1093\/brain\/awr128","volume":"134","author":"L Haider","year":"2011","unstructured":"Haider, L. et al. Oxidative damage in multiple sclerosis lesions. Brain 134, 1914\u20131924. https:\/\/doi.org\/10.1093\/brain\/awr128 (2011).","journal-title":"Brain"},{"key":"7429_CR5","doi-asserted-by":"publisher","unstructured":"Alrouji, M. et al. Investigating the effect of cigarette smoking on serum uric acid levels in multiple sclerosis patients: A cross sectional study. Brain Sci. 13 https:\/\/doi.org\/10.3390\/brainsci13050800 (2023).","DOI":"10.3390\/brainsci13050800"},{"key":"7429_CR6","doi-asserted-by":"publisher","unstructured":"Pegoretti, V. et al. Inflammation and oxidative stress in multiple sclerosis: consequences for therapy development. Oxid. Med. Cell Longev. 7191080 (2020).https:\/\/doi.org\/10.1155\/2020\/7191080","DOI":"10.1155\/2020\/7191080"},{"key":"7429_CR7","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1523\/JNEUROSCI.5804-08.2009","volume":"29","author":"D Centonze","year":"2009","unstructured":"Centonze, D. et al. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J. Neurosci. 29, 3442\u20133452. https:\/\/doi.org\/10.1523\/JNEUROSCI.5804-08.2009 (2009).","journal-title":"J. Neurosci."},{"key":"7429_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.2174\/187152712801661194","volume":"11","author":"GR Campbell","year":"2012","unstructured":"Campbell, G. R. & Mahad, D. J. Clonal expansion of mitochondrial DNA deletions and the progression of multiple sclerosis. CNS Neurol. Disord Drug Targets. 11, 589\u2013597. https:\/\/doi.org\/10.2174\/187152712801661194 (2012).","journal-title":"CNS Neurol. Disord Drug Targets"},{"key":"7429_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","volume":"14","author":"DH Mahad","year":"2015","unstructured":"Mahad, D. H., Trapp, B. D. & Lassmann, H. Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol. 14, 183\u2013193. https:\/\/doi.org\/10.1016\/S1474-4422(14)70256-X (2015).","journal-title":"Lancet Neurol."},{"key":"7429_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1748-1716.1987.tb08057.x","volume":"129","author":"SP Olesen","year":"1987","unstructured":"Olesen, S. P. Free oxygen radicals decrease electrical resistance of microvascular endothelium in brain. Acta Physiol. Scand. 129, 181\u2013187. https:\/\/doi.org\/10.1111\/j.1748-1716.1987.tb08057.x (1987).","journal-title":"Acta Physiol. Scand."},{"key":"7429_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jchromb.2016.02.010","volume":"1019","author":"A Suneetha","year":"2016","unstructured":"Suneetha, A. & Raja Rajeswari, K. Role of dimethyl fumarate in oxidative stress of multiple sclerosis: A review. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 1019, 15\u201320. https:\/\/doi.org\/10.1016\/j.jchromb.2016.02.010 (2016).","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"key":"7429_CR12","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41590-020-0654-0","volume":"21","author":"AS Mendiola","year":"2020","unstructured":"Mendiola, A. S. et al. Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. Nat. Immunol. 21, 513\u2013524. https:\/\/doi.org\/10.1038\/s41590-020-0654-0 (2020).","journal-title":"Nat. Immunol."},{"key":"7429_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.expneurol.2015.11.010","volume":"277","author":"K Ohl","year":"2016","unstructured":"Ohl, K., Tenbrock, K. & Kipp, M. Oxidative stress in multiple sclerosis: central and peripheral mode of action. Exp. Neurol. 277, 58\u201367. https:\/\/doi.org\/10.1016\/j.expneurol.2015.11.010 (2016).","journal-title":"Exp. Neurol."},{"key":"7429_CR14","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.freeradbiomed.2008.09.023","volume":"45","author":"J van Horssen","year":"2008","unstructured":"van Horssen, J. et al. Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression. Free Radic Biol. Med. 45, 1729\u20131737. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2008.09.023 (2008).","journal-title":"Free Radic Biol. Med."},{"key":"7429_CR15","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2217\/bmm-2016-0097","volume":"10","author":"R Ibitoye","year":"2016","unstructured":"Ibitoye, R. et al. Oxidative stress-related biomarkers in multiple sclerosis: a review. Biomark. Med. 10, 889\u2013902. https:\/\/doi.org\/10.2217\/bmm-2016-0097 (2016).","journal-title":"Biomark. Med."},{"key":"7429_CR16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s004150170158","volume":"248","author":"G Giovannoni","year":"2001","unstructured":"Giovannoni, G. et al. Serum inflammatory markers and clinical\/mri markers of disease progression in multiple sclerosis. J. Neurol. 248, 487\u2013495. https:\/\/doi.org\/10.1007\/s004150170158 (2001).","journal-title":"J. Neurol."},{"key":"7429_CR17","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1007\/s11011-021-00786-5","volume":"36","author":"V Borisovs","year":"2021","unstructured":"Borisovs, V., Bodrenko, J., Kalnina, J. & Sjakste, N. Nitrosative stress parameters and the level of oxidized DNA bases in patients with multiple sclerosis. Metab. Brain Dis. 36, 1935\u20131941. https:\/\/doi.org\/10.1007\/s11011-021-00786-5 (2021).","journal-title":"Metab. Brain Dis."},{"key":"7429_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/13524585211017013","volume":"28","author":"A Kalinowski","year":"2022","unstructured":"Kalinowski, A. et al. The timed 25-foot walk in a large cohort of multiple sclerosis patients. Mult Scler. 28, 289\u2013299. https:\/\/doi.org\/10.1177\/13524585211017013 (2022).","journal-title":"Mult Scler."},{"key":"7429_CR19","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1177\/1352458517690824","volume":"23","author":"P Feys","year":"2017","unstructured":"Feys, P. et al. The Nine-Hole Peg test as a manual dexterity performance measure for multiple sclerosis. Mult Scler. 23, 711\u2013720. https:\/\/doi.org\/10.1177\/1352458517690824 (2017).","journal-title":"Mult Scler."},{"key":"7429_CR20","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1191\/1352458502ms839oa","volume":"8","author":"P Flachenecker","year":"2002","unstructured":"Flachenecker, P. et al. Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler. 8, 523\u2013526. https:\/\/doi.org\/10.1191\/1352458502ms839oa (2002).","journal-title":"Mult Scler."},{"key":"7429_CR21","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT BECK","year":"1961","unstructured":"Beck, A. T., Mendelson, W. A. R. D. C. H., Mock, M., Erbaugh, J. & J. & An inventory for measuring depression. Arch. Gen. Psychiatry. 4, 561\u2013571. https:\/\/doi.org\/10.1001\/archpsyc.1961.01710120031004 (1961).","journal-title":"Arch. Gen. Psychiatry"},{"key":"7429_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"E Group","year":"1990","unstructured":"Group, E. EuroQol\u2013a new facility for the measurement of health-related quality of life. Health Policy. 16, 199\u2013208. https:\/\/doi.org\/10.1016\/0168-8510(90)90421-9 (1990).","journal-title":"Health Policy"},{"key":"7429_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jns.2017.08.019","volume":"381","author":"M Beier","year":"2017","unstructured":"Beier, M. et al. Proposed cut scores for tests of the brief international cognitive assessment of multiple sclerosis (BICAMS). J. Neurol. Sci. 381, 110\u2013116. https:\/\/doi.org\/10.1016\/j.jns.2017.08.019 (2017).","journal-title":"J. Neurol. Sci."},{"key":"7429_CR24","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1080\/01926230290166724","volume":"30","author":"R Kohen","year":"2002","unstructured":"Kohen, R. & Nyska, A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol. Pathol. 30, 620\u2013650. https:\/\/doi.org\/10.1080\/01926230290166724 (2002).","journal-title":"Toxicol. Pathol."},{"key":"7429_CR25","doi-asserted-by":"publisher","first-page":"12761","DOI":"10.1038\/s41598-022-16840-w","volume":"12","author":"D Moezzi","year":"2022","unstructured":"Moezzi, D. et al. Expression of antioxidant enzymes in lesions of multiple sclerosis and its models. Sci. Rep. 12, 12761. https:\/\/doi.org\/10.1038\/s41598-022-16840-w (2022).","journal-title":"Sci. Rep."},{"key":"7429_CR26","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s13760-012-0059-4","volume":"112","author":"A Acar","year":"2012","unstructured":"Acar, A. et al. Evaluation of serum oxidant\/antioxidant balance in multiple sclerosis. Acta Neurol. Belg. 112, 275\u2013280. https:\/\/doi.org\/10.1007\/s13760-012-0059-4 (2012).","journal-title":"Acta Neurol. Belg."},{"key":"7429_CR27","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1007\/s10072-020-04928-y","volume":"42","author":"D Obradovic","year":"2021","unstructured":"Obradovic, D., Andjelic, T., Ninkovic, M., Dejanovic, B. & Kotur-Stevuljevic, J. Superoxide dismutase (SOD), advanced oxidation protein products (AOPP), and disease-modifying treatment are related to better relapse recovery after corticosteroid treatment in multiple sclerosis. Neurol. Sci. 42, 3241\u20133247. https:\/\/doi.org\/10.1007\/s10072-020-04928-y (2021).","journal-title":"Neurol. Sci."},{"key":"7429_CR28","doi-asserted-by":"publisher","unstructured":"Tavassolifar, M. J. et al. Redox Imbalance in CD4\u2009+\u2009T cells of relapsing-remitting multiple sclerosis patients. Oxid Med Cell Longev. 8860813 (2020).https:\/\/doi.org\/10.1155\/2020\/8860813","DOI":"10.1155\/2020\/8860813"},{"key":"7429_CR29","doi-asserted-by":"publisher","first-page":"103228","DOI":"10.1016\/j.msard.2021.103228","volume":"56","author":"AA Rasoul","year":"2021","unstructured":"Rasoul, A. A. et al. The role of oxidative stress and haematological parameters in relapsing-remitting multiple sclerosis in Kurdish population. Mult Scler. Relat. Disord. 56, 103228. https:\/\/doi.org\/10.1016\/j.msard.2021.103228 (2021).","journal-title":"Mult Scler. Relat. Disord"},{"key":"7429_CR30","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s10571-013-9944-5","volume":"33","author":"S Ljubisavljevic","year":"2013","unstructured":"Ljubisavljevic, S. et al. Cerebrospinal fluid and plasma oxidative stress biomarkers in different clinical phenotypes of neuroinflammatory acute attacks. Conceptual accession: from fundamental to clinic. Cell. Mol. Neurobiol. 33, 767\u2013777. https:\/\/doi.org\/10.1007\/s10571-013-9944-5 (2013).","journal-title":"Cell. Mol. Neurobiol."},{"key":"7429_CR31","first-page":"116","volume":"48","author":"K Mitosek-Szewczyk","year":"2010","unstructured":"Mitosek-Szewczyk, K., Gordon-Krajcer, W., Walendzik, P. & Stelmasiak, Z. Free radical peroxidation products in cerebrospinal fluid and serum of patients with multiple sclerosis after glucocorticoid therapy. Folia Neuropathol. 48, 116\u2013122 (2010).","journal-title":"Folia Neuropathol."},{"key":"7429_CR32","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/s1734-1140(13)71039-9","volume":"65","author":"I Tasset","year":"2013","unstructured":"Tasset, I. et al. Effect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosis. Pharmacol. Rep. 65, 624\u2013631. https:\/\/doi.org\/10.1016\/s1734-1140(13)71039-9 (2013).","journal-title":"Pharmacol. Rep."},{"key":"7429_CR33","first-page":"235","volume":"67","author":"M Adamczyk-Sowa","year":"2016","unstructured":"Adamczyk-Sowa, M. et al. Effect of melatonin supplementation on plasma lipid hydroperoxides, homocysteine concentration and chronic fatigue syndrome in multiple sclerosis patients treated with interferons-beta and Mitoxantrone. J. Physiol. Pharmacol. 67, 235\u2013242 (2016).","journal-title":"J. Physiol. Pharmacol."},{"key":"7429_CR34","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1177\/1352458514533400","volume":"20","author":"AN Carvalho","year":"2014","unstructured":"Carvalho, A. N., Lim, J. L., Nijland, P. G., Witte, M. E. & Van Horssen, J. Glutathione in multiple sclerosis: more than just an antioxidant? Mult Scler. 20, 1425\u20131431. https:\/\/doi.org\/10.1177\/1352458514533400 (2014).","journal-title":"Mult Scler."},{"key":"7429_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0022-510x(80)90150-1","volume":"48","author":"GE Jensen","year":"1980","unstructured":"Jensen, G. E., Gissel-Nielsen, G. & Clausen, J. Leucocyte glutathione peroxidase activity and selenium level in multiple sclerosis. J. Neurol. Sci. 48, 61\u201367. https:\/\/doi.org\/10.1016\/0022-510x(80)90150-1 (1980).","journal-title":"J. Neurol. Sci."},{"key":"7429_CR36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0022-510x(84)90107-2","volume":"63","author":"GE Jensen","year":"1984","unstructured":"Jensen, G. E. & Clausen, J. Glutathione peroxidase and reductase, glucose-6-phosphate dehydrogenase and catalase activities in multiple sclerosis. J. Neurol. Sci. 63, 45\u201353. https:\/\/doi.org\/10.1016\/0022-510x(84)90107-2 (1984).","journal-title":"J. Neurol. Sci."},{"key":"7429_CR37","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.clinbiochem.2012.01.023","volume":"45","author":"I Tasset","year":"2012","unstructured":"Tasset, I. et al. Peripheral oxidative stress in relapsing-remitting multiple sclerosis. Clin. Biochem. 45, 440\u2013444. https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.01.023 (2012).","journal-title":"Clin. Biochem."},{"key":"7429_CR38","first-page":"119","volume":"14","author":"V Calabrese","year":"1994","unstructured":"Calabrese, V., Raffaele, R., Cosentino, E. & Rizza, V. Changes in cerebrospinal fluid levels of malondialdehyde and glutathione reductase activity in multiple sclerosis. Int. J. Clin. Pharmacol. Res. 14, 119\u2013123 (1994).","journal-title":"Int. J. Clin. Pharmacol. Res."},{"key":"7429_CR39","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.3390\/12071496","volume":"12","author":"R Apak","year":"2007","unstructured":"Apak, R. et al. Comparative evaluation of various total antioxidant capacity assays applied to phenolic compounds with the CUPRAC assay. Molecules 12, 1496\u20131547. https:\/\/doi.org\/10.3390\/12071496 (2007).","journal-title":"Molecules"},{"key":"7429_CR40","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/1028415031000115945","volume":"6","author":"HT Besler","year":"2003","unstructured":"Besler, H. T. & Como\u011flu, S. Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis. Nutr. Neurosci. 6, 189\u2013196. https:\/\/doi.org\/10.1080\/1028415031000115945 (2003).","journal-title":"Nutr. Neurosci."},{"key":"7429_CR41","doi-asserted-by":"publisher","unstructured":"Armon-Omer, A. et al. New insights on the nutrition status and antioxidant capacity in multiple sclerosis patients. Nutrients 11 https:\/\/doi.org\/10.3390\/nu11020427 (2019).","DOI":"10.3390\/nu11020427"},{"key":"7429_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.17305\/bjbms.2011.2620","volume":"11","author":"A Had\u017eovi\u0107-D\u017euvo","year":"2011","unstructured":"Had\u017eovi\u0107-D\u017euvo, A. et al. Serum total antioxidant capacity in patients with multiple sclerosis. Bosn J. Basic. Med. Sci. 11, 33\u201336. https:\/\/doi.org\/10.17305\/bjbms.2011.2620 (2011).","journal-title":"Bosn J. Basic. Med. Sci."},{"key":"7429_CR43","doi-asserted-by":"publisher","unstructured":"Adamczyk, B., Wawrzyniak, S., Kasperczyk, S. & Adamczyk-Sowa, M. The evaluation of oxidative stress parameters in serum patients with relapsing-remitting multiple sclerosis treated with II-Line Immunomodulatory therapy. Oxid. Med. Cell. Longev. 2017 (9625806). https:\/\/doi.org\/10.1155\/2017\/9625806 (2017).","DOI":"10.1155\/2017\/9625806"},{"key":"7429_CR44","doi-asserted-by":"publisher","first-page":"106377","DOI":"10.1016\/j.clineuro.2020.106377","volume":"200","author":"NB Khajenobar","year":"2021","unstructured":"Khajenobar, N. B. et al. Comparison between cerebrospinal fluid and serum levels of myelin-associated glycoprotein, total antioxidant capacity, and 8-hydroxy-2\u2019-deoxyguanosine in patients with multiple sclerosis. Clin. Neurol. Neurosurg. 200, 106377. https:\/\/doi.org\/10.1016\/j.clineuro.2020.106377 (2021).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"7429_CR45","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1179\/1476830513Y.0000000060","volume":"17","author":"M Khalili","year":"2014","unstructured":"Khalili, M. et al. Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: a randomized controlled clinical trial. Nutr. Neurosci. 17, 16\u201320. https:\/\/doi.org\/10.1179\/1476830513Y.0000000060 (2014).","journal-title":"Nutr. Neurosci."},{"key":"7429_CR46","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.4161\/cc.28295","volume":"13","author":"E Benedetti","year":"2014","unstructured":"Benedetti, E. et al. Involvement of peroxisome proliferator-activated receptor \u03b2\/\u03b4 (PPAR \u03b2\/\u03b4) in BDNF signaling during aging and in alzheimer disease: possible role of 4-hydroxynonenal (4-HNE). Cell. Cycle. 13, 1335\u20131344. https:\/\/doi.org\/10.4161\/cc.28295 (2014).","journal-title":"Cell. Cycle"},{"key":"7429_CR47","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/ana.410440419","volume":"44","author":"RG Smith","year":"1998","unstructured":"Smith, R. G., Henry, Y. K., Mattson, M. P. & Appel, S. H. Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Ann. Neurol. 44, 696\u2013699. https:\/\/doi.org\/10.1002\/ana.410440419 (1998).","journal-title":"Ann. Neurol."},{"key":"7429_CR48","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jns.2016.12.039","volume":"373","author":"KPZ Ferreira","year":"2017","unstructured":"Ferreira, K. P. Z. et al. Disease progression and oxidative stress are associated with higher serum ferritin levels in patients with multiple sclerosis. J. Neurol. Sci. 373, 236\u2013241. https:\/\/doi.org\/10.1016\/j.jns.2016.12.039 (2017).","journal-title":"J. Neurol. Sci."},{"key":"7429_CR49","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S1474-4422(08)70259-X","volume":"7","author":"ND Chiaravalloti","year":"2008","unstructured":"Chiaravalloti, N. D. & DeLuca, J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 7, 1139\u20131151. https:\/\/doi.org\/10.1016\/S1474-4422(08)70259-X (2008).","journal-title":"Lancet Neurol."},{"key":"7429_CR50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12974-017-1026-z","volume":"15","author":"I Hajjar","year":"2018","unstructured":"Hajjar, I. et al. Oxidative stress predicts cognitive decline with aging in healthy adults: an observational study. J. Neuroinflammation. 15, 17. https:\/\/doi.org\/10.1186\/s12974-017-1026-z (2018).","journal-title":"J. Neuroinflammation"},{"key":"7429_CR51","first-page":"80","volume":"19","author":"S Tarbali","year":"2016","unstructured":"Tarbali, S. & Khezri, S. Vitamin D3 attenuates oxidative stress and cognitive deficits in a model of toxic demyelination. Iran. J. Basic. Med. Sci. 19, 80\u201388 (2016).","journal-title":"Iran. J. Basic. Med. Sci."},{"key":"7429_CR52","doi-asserted-by":"publisher","first-page":"103432","DOI":"10.1016\/j.msard.2021.103432","volume":"57","author":"A Naseri","year":"2022","unstructured":"Naseri, A. et al. Circulatory antioxidant and oxidative stress markers are in correlation with demographics but not cognitive functions in multiple sclerosis patients. Mult Scler. Relat. Disord. 57, 103432. https:\/\/doi.org\/10.1016\/j.msard.2021.103432 (2022).","journal-title":"Mult Scler. Relat. Disord"},{"key":"7429_CR53","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/070674370404900302","volume":"49","author":"A Feinstein","year":"2004","unstructured":"Feinstein, A. The neuropsychiatry of multiple sclerosis. Can. J. Psychiatry. 49, 157\u2013163. https:\/\/doi.org\/10.1177\/070674370404900302 (2004).","journal-title":"Can. J. Psychiatry"},{"key":"7429_CR54","doi-asserted-by":"publisher","first-page":"6282","DOI":"10.1007\/s12035-017-0843-5","volume":"55","author":"G Morris","year":"2018","unstructured":"Morris, G. et al. Multiple Immune-Inflammatory and oxidative and nitrosative stress pathways explain the frequent presence of depression in multiple sclerosis. Mol. Neurobiol. 55, 6282\u20136306. https:\/\/doi.org\/10.1007\/s12035-017-0843-5 (2018).","journal-title":"Mol. Neurobiol."},{"key":"7429_CR55","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/jnnp.2005.074948","volume":"77","author":"G Giovannoni","year":"2006","unstructured":"Giovannoni, G. Multiple sclerosis related fatigue. J. Neurol. Neurosurg. Psychiatry. 77, 2\u20133. https:\/\/doi.org\/10.1136\/jnnp.2005.074948 (2006).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"7429_CR56","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1191\/135248506ms1373ed","volume":"12","author":"L Krupp","year":"2006","unstructured":"Krupp, L. Fatigue is intrinsic to multiple sclerosis (MS) and is the most commonly reported symptom of the disease. Mult Scler. 12, 367\u2013368. https:\/\/doi.org\/10.1191\/135248506ms1373ed (2006).","journal-title":"Mult Scler."},{"key":"7429_CR57","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s12035-015-9090-9","volume":"53","author":"G Morris","year":"2016","unstructured":"Morris, G., Berk, M., Galecki, P., Walder, K. & Maes, M. The Neuro-Immune pathophysiology of central and peripheral fatigue in systemic Immune-Inflammatory and Neuro-Immune diseases. Mol. Neurobiol. 53, 1195\u20131219. https:\/\/doi.org\/10.1007\/s12035-015-9090-9 (2016).","journal-title":"Mol. Neurobiol."},{"key":"7429_CR58","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.clinbiochem.2014.09.024","volume":"48","author":"L Pasquali","year":"2015","unstructured":"Pasquali, L. et al. Plasmatic oxidative stress biomarkers in multiple sclerosis: relation with clinical and demographic characteristics. Clin. Biochem. 48, 19\u201323. https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.09.024 (2015).","journal-title":"Clin. Biochem."},{"key":"7429_CR59","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/acn3.51325","volume":"8","author":"KM Krysko","year":"2021","unstructured":"Krysko, K. M. et al. A pilot study of oxidative pathways in MS fatigue: randomized trial of N-acetyl cysteine. Ann. Clin. Transl Neurol. 8, 811\u2013824. https:\/\/doi.org\/10.1002\/acn3.51325 (2021).","journal-title":"Ann. Clin. Transl Neurol."},{"key":"7429_CR60","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s13760-018-1015-8","volume":"120","author":"V Katarina","year":"2020","unstructured":"Katarina, V., Gordana, T., Svetlana, M. D. & Milica, B. Oxidative stress and neuroinflammation should be both considered in the occurrence of fatigue and depression in multiple sclerosis. Acta Neurol. Belg. 120, 853\u2013861. https:\/\/doi.org\/10.1007\/s13760-018-1015-8 (2020).","journal-title":"Acta Neurol. Belg."},{"key":"7429_CR61","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/brain\/awq386","volume":"134","author":"RA Linker","year":"2011","unstructured":"Linker, R. A. et al. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain 134, 678\u2013692. https:\/\/doi.org\/10.1093\/brain\/awq386 (2011).","journal-title":"Brain"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07429-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07429-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07429-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T22:18:38Z","timestamp":1751408318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07429-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7429"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-07429-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4354044\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"1 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22983"}}